or Try an Advanced Search...

    Actinic Keratosis Stocks List

    Symbol Grade Name % Change
    BHC A Bausch Health Companies Inc. 6.30
    BFRI D Biofrontera Inc. -11.38
    View As Page of Charts
    Related Industries: Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Dermatology Acne Antineoplastic Drugs Atopic Dermatitis Biopharmaceutical Biotechnology Clinical Medicine Colitis Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Health Sciences Irritable Bowel Syndrome

    Related ETFs - A few ETFs which own one or more of the above listed Actinic Keratosis stocks.

    Symbol Grade Name Weight
    FLHY C Franklin Liberty High Yield Corporate ETF 1.16
    View all Actinic Keratosis ETFs...
    Compare ETFs

        Actinic Keratosis Stocks Recent News

        Date Stock Title
        Nov 1 BHC Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
        Nov 1 BFRI Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
        Oct 31 BFRI Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
        Oct 31 BHC Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
        Oct 31 BHC Bausch Health Companies Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 BHC Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript
        Oct 31 BHC Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics
        Oct 31 BHC Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates
        Oct 30 BHC Bausch: Q3 Earnings Snapshot
        Oct 30 BHC Bausch Health raises 2024 revenue guidance
        Oct 30 BHC Bausch Health Companies GAAP EPS of -$0.23 misses by $0.37, revenue of $2.51B beats by $90M
        Oct 30 BHC Bausch Health up 5.5% in New York Trade as It Reports a Higher Adjusted Third-Quarter Profit, Ups Guidance
        Oct 30 BHC Bausch Health Announces Third Quarter 2024 Results
        Oct 30 BHC Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
        Oct 30 BHC Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates
        Oct 30 BHC Bausch + Lomb: Q3 Earnings Snapshot
        Oct 29 BHC Bausch Health Companies Q3 2024 Earnings Preview
        Oct 27 BHC ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
        Oct 26 BHC Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
        Related Industries: Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Dermatology Acne Antineoplastic Drugs Atopic Dermatitis Biopharmaceutical Biotechnology Clinical Medicine Colitis Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Health Sciences Irritable Bowel Syndrome
        Actinic Keratosis

        Actinic keratosis (AK) is a pre-cancerous skin condition caused by long-term sun exposure. It is characterized by scaly, rough patches on the skin that may be red, pink, or skin-colored. AK is most commonly found on the face, scalp, ears, neck, lips, and the back of the hands. Treatment options include topical creams, cryotherapy, and laser therapy.

        Browse All Tags